• Publications
  • Influence
Left Ventricular Hypertrophy and Antiarrhythmic Drugs in Atrial Fibrillation: Impact on Mortality
Despite sparse clinical data, current atrial fibrillation (AF) guidelines favor amiodarone as a drug of choice for patients with left ventricular hypertrophy (LVH).
Clinical presentation of ventricular-Hisian and ventricular-nodal accessory pathways.
BACKGROUND Narrow QRS tachycardia or premature beat with bystander atrial activation or ventricular-atrial dissociation is an unusual arrhythmia that can present diagnostic and therapeuticExpand
Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.
BACKGROUND A significant proportion of implantable cardioverter-defibrillators (ICDs) have been subject to Food and Drug Administration (FDA) advisories. The impact of device advisories on mortalityExpand
Operator learning curve and clinical outcomes of zero fluoroscopy catheter ablation of atrial fibrillation, supraventricular tachycardia, and ventricular arrhythmias
Purpose To investigate the learning curve for atrial fibrillation (AF), supraventricular tachycardia (SVT), and premature ventricular contraction (PVC) radiofrequency ablation (RFA) using zeroExpand
Percutaneous extraction of stented device leads.
BACKGROUND There are limited published data regarding the percutaneous extraction of device leads jailed by a venous stent. OBJECTIVE In this study we assessed the feasibility and safety ofExpand
Clinical implications of real time implantable cardioverter-defibrillator high voltage lead short circuit detection
We described a clinical case of a successful defibrillation despite initial detection of low high voltage impedance using Dynamic Tx algorithm, by withholding therapy if there is a short circuit and changing its shocking vector to an alternate one. Expand